Not Signed In -
Dexamethasone Tablets |
Decadron; Dexone; Hexadrol |
Dexamethasone Systematic (IUPAC) name 9-fluoro-11β,17,21-trihydroxy-16a- methylpregna-1,4-diene-3,20-dione Identifiers CAS number 50-02-2 ATC code A01AC02 C05AA09, D07AB19, H02AB02, R01AD03, S01BA01, S02BA06, S03BA01 PubChem 5743 DrugBank APRD00674 Chemical data Formula C22H29FO5 Mol. weight 392.464 g/mol Pharmacokinetic data Bioavailability ? Metabolism hepatic Half life 170-370 min Excretion renal Therapeutic considerations Pregnancy ca ...
Wikipedia - [full article]
Dexamethasone Tablets Clinical Trials
- Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
Multiple Myeloma
- Gemcitabine, Dexamethasone and Cisplatin Versus Dexamethasone, Cytarabine, Cisplatin in Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00089817 - Recruiting
Lymphoma
- Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone,Plus Systemic Dexamethasone
ClinicalTrials.gov Identifier: NCT00519584 - Recruiting
Pain
- A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00424047 - Active, not recruiting
Multiple Myeloma
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
Pain
- Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00344422 - Active, not recruiting
M-Protein; Multiple Myeloma; Myeloma; Myeloma Proteins
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
Parkinson's Disease
- IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00200681 - Recruiting
Multiple Myeloma
- Phase 1/2 Study of VELCADE®, Dexamethasone, and Revlimid® Versus VELCADE, Dexamethasone, Cyclophosphamide, and Revlimid in Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00507442 - Recruiting
Multiple Myeloma
- Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
ClinicalTrials.gov Identifier: NCT00522392 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00176293 - Active, not recruiting
Prostate Cancer
- CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00056160 - Active, not recruiting
Multiple Myeloma
- Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00151203 - Active, not recruiting
Multiple Myeloma
- Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00116961 - Active, not recruiting
Multiple Myeloma
- A Pilot Study of Combination Therapy with VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00135187 - Active, not recruiting
Multiple Myeloma
- Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00458705 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- A Multicenter, Open-Label, Single-Arm, Expanded Access Program For Lenalidomide Plus Dexamethasone In Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00179647 - Recruiting
Multiple Myeloma
- A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea.
ClinicalTrials.gov Identifier: NCT00272285 - Active, not recruiting
Vomiting; Nausea
- Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00441168 - Recruiting
Multiple Myeloma
- The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
ClinicalTrials.gov Identifier: NCT00119002 - Recruiting
Bronchiolitis, Viral
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
primary systemic amyloidosis
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
ClinicalTrials.gov Identifier: NCT00074191 - Active, not recruiting
intraocular lymphoma; primary central nervous system lymphoma
- Dexamethasone Study
ClinicalTrials.gov Identifier: NCT00152867 - Recruiting
Cancer; Quality of Life; Emesis
- Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
ClinicalTrials.gov Identifier: NCT00074178 - Active, not recruiting
primary central nervous system lymphoma; intraocular lymphoma
- Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00089167 - Active, not recruiting
primary systemic amyloidosis
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
- Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00030069 - Recruiting
Myelodysplastic Syndromes
- Aprepitant, Ondansetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
ClinicalTrials.gov Identifier: NCT00248547 - Active, not recruiting
Cancer
- Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
Pain
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
ClinicalTrials.gov Identifier: NCT00577993 - Active, not recruiting
Lymphoma
- Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00250926 - Active, not recruiting
Waldenstrom's Macroglobulinemia
- An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
Analgesia
- Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
Allergy
- Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017069 - Active, not recruiting
refractory plasma cell neoplasm; stage II multiple myeloma; stage III multiple myeloma
- Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
Transplantation; Kidney Transplantation; Immunosuppression
- Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
Parkinson Disease
- Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
Allergy
- A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
ClinicalTrials.gov Identifier: NCT00437229 - Active, not recruiting
Healthy Adult Volunteer
- A Multicentre, Single-Arm, Open-Label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00420849 - Active, not recruiting
Multiple Myeloma
- Dexamethasone or Dexamethasone in Combination with Thalidomide as Salvage Therapy
ClinicalTrials.gov Identifier: NCT00083902 - Completed
Multiple Myeloma
- Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00227682 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Dexamethasone for Palliation - Brain Metastases
ClinicalTrials.gov Identifier: NCT00188864 - Recruiting
Neoplasm Metastasis
- A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
Schizophrenia; Psychotic Disorders
- A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
Analgesics, Opioid.; Pain
- A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00478777 - Active, not recruiting
Relapsed or Refractory Multiple Myeloma
- Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00375791 - Active, not recruiting
Multiple Myeloma
- Dexamethasone for Symptom Burden in Cancer Patients
ClinicalTrials.gov Identifier: NCT00489307 - Recruiting
Solid Tumors
- Bortezomib-Dexamethasone-Doxorubicin-Study
ClinicalTrials.gov Identifier: NCT00401804 - Recruiting
Multiple Myeloma; Renal Insuficiency
- Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
Chronic Hepatitis B
- A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
Schizophrenia
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
Epilepsy, Partial
- Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00084864 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica
ClinicalTrials.gov Identifier: NCT00516009 - Recruiting
RADICULAR PAIN
- Total Therapy II
ClinicalTrials.gov Identifier: NCT00083551 - Active, not recruiting
Multiple Myeloma
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003397 - Active, not recruiting
Lymphoma
- Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns with Lupus
ClinicalTrials.gov Identifier: NCT00007358 - Recruiting
Congenital heart block; Neonatal lupus; Atrioventricular nodal dysfunction; Myocardial injury
- Lopinavir Capsules to Kaletra or Invirase Tablets
ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
HIV Infections
- Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00261612 - Active, not recruiting
Lymphoma, Mantle-Cell
- Drugs to Reduce the Side Effects of Chemotherapy
ClinicalTrials.gov Identifier: NCT00003213 - Active, not recruiting
solid tumor; Nausea; Vomiting
- Randomized Study of Albendazole in Patients with Epilepsy Due to Neurocysticercosis
ClinicalTrials.gov Identifier: NCT00004403 - Active, not recruiting
Epilepsy; Cysticercosis
- Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
Lymphoma; Leukemia
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003402 - Active, not recruiting
Lymphocytic Lymphoma
- Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov Identifier: NCT00258245 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
Essential Hypertension
- Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
ClinicalTrials.gov Identifier: NCT00042367 - Active, not recruiting
Brain Tumors
- Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of PVR
ClinicalTrials.gov Identifier: NCT00370760 - Recruiting
Proliferative Vitreoretinopathy
- Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00564889 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Velcade and Dexamethasone in Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00391157 - Active, not recruiting
Multiple Myeloma
- A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
ClinicalTrials.gov Identifier: NCT00139854 - Completed
Anxiety
- Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
ClinicalTrials.gov Identifier: NCT00492284 - Recruiting
Choroidal Neovascularization; Macular Degeneration
- DTPACE followed by Tandem Transplant with MEL 200 versus MEL/DTPACE Hybrid and DTPACE Consolidation
ClinicalTrials.gov Identifier: NCT00083915 - Active, not recruiting
Multiple Myeloma
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
Allergy
- Phase 2 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive ALL
ClinicalTrials.gov Identifier: NCT00130195 - Active, not recruiting
Acute Lymphoblastic Leukemia
- A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
ClinicalTrials.gov Identifier: NCT00520767 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
ClinicalTrials.gov Identifier: NCT00561301 - Recruiting
Lymphoma
- Rituximab and Dexamethasone in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00244855 - Recruiting
Lymphoma
- Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis
ClinicalTrials.gov Identifier: NCT00213226 - Recruiting
Bronchiolitis
- The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery
ClinicalTrials.gov Identifier: NCT00236223 - Recruiting
Pain, Postoperative
- To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
ClinicalTrials.gov Identifier: NCT00372294 - Recruiting
Toxoplasmic Chorioretinitis
- Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Having a Tonsillectomy
ClinicalTrials.gov Identifier: NCT00378547 - Recruiting
Pain, Postoperative
- High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
ClinicalTrials.gov Identifier: NCT00451594 - Recruiting
Idiopathic Thrombocytopenic Purpura
- Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma
ClinicalTrials.gov Identifier: NCT00166439 - Recruiting
Lymphoma
- Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma
ClinicalTrials.gov Identifier: NCT00275106 - Recruiting
Lymphoma
- Dexamethasone for Cardiac Surgery Trial
ClinicalTrials.gov Identifier: NCT00293592 - Recruiting
Systemic Inflammatory Response Syndrome; Cardiac Diseases; Postoperative Complications
- Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
ClinicalTrials.gov Identifier: NCT00335920 - Recruiting
Sudden Deafness
- Dexamethasone for Paediatric Adeno-Tonsillectomy - A Dose-Finding Study
ClinicalTrials.gov Identifier: NCT00403806 - Recruiting
Postoperative Nausea and Vomiting; Postoperative Pain
- Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
Allergy
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00112879 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
Onychomycosis of the Toenail
Resources
- Decadron (Drug Digest)
- Dexamethasone Tablets (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
